Clinical trial
Treatment of Orthostatic Intolerance
NCT00262470 · Satish R. Raj, Other · Active, not recruiting
Key facts
| NCT number | NCT00262470 |
|---|---|
| Title | Treatment of Orthostatic Intolerance |
| Official title | Treatment of Orthostatic Intolerance |
| Lead sponsor | Satish R. Raj, Other |
| Collaborators | National Center for Advancing Translational Sciences (NCATS) NIH |
| Status | Active, not recruiting |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Tachycardia, Chronic Orthostatic Intolerance |
| Intervention type | Device, Dietary Supplement, Drug, Other, Procedure, Radiation |
| Interventions | Acetazolamide, Atomoxetine, NO Drug, Clonidine, Entacapone, Entacapone & Propranolol, Atomoxetine & Propranolol, Indomethacin, Mecamylamine, Isosorbide Dinitrate and 13 more |
| Enrollment | 150 |
| Start date | Apr 1, 1997 |
| Primary completion | Dec 1, 2029 |
| Completion | Dec 1, 2029 |
| First posted | Dec 6, 2005 |
| Last update posted | Oct 8, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: